Elan Vital Research Foundation
Elan Vital Research Foundation (EVRF)
A 501(c)3 Non-Profit Organization
On June 1, 2002, Andrew Pauli, M.D. founded the Élan Vital Research Foundation.
The Mission of this foundation is:
EVRF intends to advance Anti-Aging and Integrative Medicine in several ways:
1. By designing and conducting research in the areas of Anti-Aging and Integrative Medicine.
2. By supporting and producing educational programs and presentations in the regional area to the community at large and to physicians.
3. By acting as an additional source of funding for clinical anti-aging services to select patients, based on need and/or focus of clinical problem.
EVRF has several projects in mind including survey research regarding anti-aging practices, mineral supplementation and documenting effects of nootropics (smart drugs) on measures of brain function.
EVRF is open to contributions of ideas, resources, time and/or money. Current needs particularly include donated services of a grant writer.
To contact, call 360.527.9785.
Headlines
Resveratrol is a component of red wine which has been linked to longevity. A recent study, by Sirtis Pharmaceuticals and University Lous Pasteur found that resveratrol protects mice against diet-induced obesity and insulin resistance, and boosts their endurance by a factor of two! Resveratrol treated mice also had larger mitochondria, the cellular energy centers found in all cells. These changes were associated with activation of the SIRT1 gene. The study by Lagouge et al, “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” was published in November 2006 in the journal Cell. The mice were fed the amount of resveratrol equivalent to that in 10,000 glasses of red wine. You cannot get enough resveratrol by drinking red wine!
Growth Hormone administration has many physiological effects in growth hormone deficient individuals. A recent review of the literature on growth hormone and cardiovascular effects concluded that: "
The relevance of the beneficial effects of GH on the cardiovascular system is strongly suggested but not fully proved." The review, authored by Burger et al, was published in
the Nov/Dec volume of the journal Endocrine Practice. It found that
typically, GH treatment reduces visceral fat and increases muscle mass, cardiac performance is improved, total cholesterol and low-density lipoprotein levels decrease by 10% to 20%, and inflammatory markers such as C-reactive protein decline.
About Us |
Site
Map |
Privacy Policy |
Contact Us | ©2007
Elan Vital Longevity Institute / The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician. This web-site is not meant to be a medical treatment facility. No claims regarding products nor insurance reimbursements of services are being made on this web-site.